Fresenius Kabi launches Omegaven for pediatric patients with parenteral nutrition-associated cholestasis in US

pharmanewsdaily- December 10, 2018 0

Fresenius Kabi, a prominent German pharmaceutical company, has introduced Omegaven (fish oil triglycerides) injectable emulsion in the United States, targeting a critical need for pediatric ... Read More